Description

The purpose of this Notice of Amendment is to notify that Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt certain uses of Fluticasone propionate.

Resources

Name	Format	Description	Link
Notice: Prescription Drug List (PDL): Fluticasone propionate	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-fluticasone-propionate.html
Notice: Prescription Drug List (PDL): Fluticasone propionate	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-propionate-fluticasone.html

Tags

Topics

Categories